AbbVie

Aktienkurs
232.08
Täglich Wechseln
7.39 3.29%
Monatlich
6.13%
Jährlich
11.03%
Q1 Prognose
224.91




Ebitda Veränderung Datum
AbbVie USD 3.52B 828M 2025-09
Abbott USD 3.09B 44M 2025-09
ALKERMES USD 100.31M 21.24M 2025-12
Amgen USD 5.14B 775M 2025-12
AstraZeneca USD 5.23B 272M 2025-09
Biogen USD 573.2M 253.7M 2025-12
BioMarin Pharmaceutical USD -5.26M 300.71M 2025-09
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Coherus Biosciences USD -44.34M 9.82M 2025-03
Eisai JPY 30.1B 6.62B 2025-12
Eli Lilly USD 7.88B 378.1M 2025-09
Gilead Sciences USD 4.03B 628M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
Infinity Pharmaceuticals USD -10.01M 1.39M 2023-06
J&J USD 9.52B 389M 2025-09
Medtronic USD 2.93B 482M 2025-12
Merck USD 8.39B 1.97B 2025-09
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
Novartis USD 5.88B 290M 2025-09
Pacira USD 38.71M 10.65M 2025-12
Perrigo USD 258.8M 37.3M 2025-09
Pfizer USD 6.08B 351M 2025-09
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 4.84B 2.95B 2025-09
UCB EUR 1.03B 334M 2025-06
Ultragenyx Pharmaceutical USD -156.79M 65.44M 2025-09
United Therapeutics USD 379.5M 83.4M 2025-12
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09
Zoetis USD 1.04B 87M 2025-09


AbbVie - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2026.